Girish Naganathan - Mar 8, 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
EVP Chief Technology Officer
Signature
By: Jereme Sylvain For: Girish Naganathan
Stock symbol
DXCM
Transactions as of
Mar 8, 2023
Transactions value $
$19
Form type
4
Date filed
3/10/2023, 02:59 PM
Previous filing
Nov 14, 2022
Next filing
Nov 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $18.80 +18.8K +59.7% $0.00* 50.2K Mar 8, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
F2 Included in this number are 50,225 unvested restricted stock units, 18,776 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 31,449 of which were granted on November 8, 2022 and shall vest through November 8, 2026.